Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures
Indranil Chattopadhyay, Jianmin Wang, Maochun Qin, et al.
Oncotarget (2016) Vol. 8, Iss. 6, pp. 10324-10347
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer
David Bader, Sean M. Hartig, Vasanta Putluri, et al.
Nature Metabolism (2018) Vol. 1, Iss. 1, pp. 70-85
Open Access | Times Cited: 147
Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
Marzieh Ehsani, Faith Oluwakemi David, Aria Baniahmad
Cancers (2021) Vol. 13, Iss. 7, pp. 1534-1534
Open Access | Times Cited: 61
Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression
Duminduni H. Angappulige, Nupam P. Mahajan, Kiran Mahajan
Trends in cancer (2024) Vol. 10, Iss. 4, pp. 369-381
Open Access | Times Cited: 9
3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression
Katelyn L. Mortenson, Courtney Dawes, Emily R. Wilson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1233-1318
Open Access | Times Cited: 19
Downregulation ofDipeptidyl Peptidase 4Accelerates Progression to Castration-Resistant Prostate Cancer
Joshua W. Russo, Ce Gao, Swati S. Bhasin, et al.
Cancer Research (2018) Vol. 78, Iss. 22, pp. 6354-6362
Open Access | Times Cited: 51
Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
Simeng Wen, Yuanjie Niu, Haojie Huang
Asian journal of urology (2019) Vol. 7, Iss. 3, pp. 203-218
Open Access | Times Cited: 51
Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
Veronica Mollica, Vincenzo Di Nunno, Alessia Cimadamore, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 43-43
Open Access | Times Cited: 43
BCAT1: A risk factor in multiple cancers based on a pan‐cancer analysis
Guo‐Sheng Li, Heqing Huang, Yao Liang, et al.
Cancer Medicine (2022) Vol. 11, Iss. 5, pp. 1396-1412
Open Access | Times Cited: 22
Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications
Lance Edward V. Lumahan, Mazia Arif, Amy E. Whitener, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 4
Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
Remi Adelaiye‐Ogala, Nur P. Damayanti, Ashley Orillion, et al.
Cancer Research (2018) Vol. 78, Iss. 11, pp. 2886-2896
Open Access | Times Cited: 33
Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype
Dali Tong
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103370-103370
Closed Access | Times Cited: 26
ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
Eric H. Kim, Dengfeng Cao, Nupam P. Mahajan, et al.
NAR Cancer (2020) Vol. 2, Iss. 3
Open Access | Times Cited: 27
Nuclear Receptor Coregulators in Hormone-Dependent Cancers
Hedieh Jafari, Shahid Hussain, Moray J. Campbell
Cancers (2022) Vol. 14, Iss. 10, pp. 2402-2402
Open Access | Times Cited: 14
Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers
S. Vincent Wu, Kun Yu, Zhengxing Lian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7556-7556
Open Access | Times Cited: 13
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe
Judith Günther, R.C. Hillig, Katja Zimmermann, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14366-14390
Open Access | Times Cited: 12
The anti-androgenic effects of cypermethrin mediated by non-classical testosterone pathway activation of mitogen-activated protein kinase cascade in mouse Sertoli cells
Qi Wang, Heng-Xue Wang, Junyu Shen, et al.
Ecotoxicology and Environmental Safety (2019) Vol. 177, pp. 58-65
Closed Access | Times Cited: 19
<p>c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells</p>
Yao Dai, Dietmar W. Siemann
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 3519-3529
Open Access | Times Cited: 18
Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
Goutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 6, pp. 1792-1806
Open Access | Times Cited: 18
Peroxisome proliferator‐activated receptor gamma controls prostate cancer cell growth through AR‐dependent and independent mechanisms
Catherine Elix, Meghan Salgia, Maya Otto‐Duessel, et al.
The Prostate (2019) Vol. 80, Iss. 2, pp. 162-172
Open Access | Times Cited: 16
Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients
Yonghao Liang, Peter Ka‐Fung Chiu, Yao Zhu, et al.
PLoS Genetics (2022) Vol. 18, Iss. 9, pp. e1010373-e1010373
Open Access | Times Cited: 9
Src family kinases engage differential pathways for encapsulation into extracellular vesicles
Chenming Ye, Cade Gosser, Ethan Daniel Runyon, et al.
Journal of Extracellular Biology (2023) Vol. 2, Iss. 6
Open Access | Times Cited: 5
Characterization of glycine‐N‐acyltransferase like 1 (GLYATL1) in prostate cancer
Marie‐Lisa Eich, Darshan S. Chandrashekar, Maria Del Carmen Rodriguez Peña, et al.
The Prostate (2019) Vol. 79, Iss. 14, pp. 1629-1639
Open Access | Times Cited: 14
Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients
Jean M. Winter, Lorraine Sheehan-Hennessy, Beibei Yao, et al.
Cancer Biomarkers (2022) Vol. 34, Iss. 3, pp. 493-503
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top